EPM2AIP1
Basic information
Region (hg38): 3:36985043-36993131
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPM2AIP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 26 | 3 | 3 |
Variants in EPM2AIP1
This is a list of pathogenic ClinVar variants found in the EPM2AIP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-36988684-C-A | Lynch syndrome | Benign (Sep 05, 2013) | ||
3-36991325-G-A | not specified | Uncertain significance (May 06, 2022) | ||
3-36991381-C-T | not specified | Uncertain significance (Jul 17, 2023) | ||
3-36991463-T-C | not specified | Uncertain significance (Feb 14, 2024) | ||
3-36991586-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
3-36991664-C-G | not specified | Uncertain significance (May 31, 2023) | ||
3-36991850-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
3-36991861-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
3-36991901-C-T | not specified | Uncertain significance (Apr 18, 2024) | ||
3-36991984-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
3-36992110-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
3-36992176-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
3-36992530-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
3-36992558-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
3-36992565-G-C | not specified | Uncertain significance (May 09, 2023) | ||
3-36992565-G-T | not specified | Uncertain significance (Oct 17, 2023) | ||
3-36992585-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
3-36992591-T-G | not specified | Uncertain significance (May 09, 2023) | ||
3-36992611-C-T | not specified | Likely benign (Aug 04, 2023) | ||
3-36992645-A-C | not specified | Uncertain significance (May 13, 2024) | ||
3-36992660-G-C | not specified | Uncertain significance (Oct 20, 2023) | ||
3-36992693-G-A | Benign (Dec 31, 2019) | |||
3-36992716-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
3-36992738-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
3-36992771-C-T | not specified | Uncertain significance (Jul 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPM2AIP1 | protein_coding | protein_coding | ENST00000322716 | 1 | 7439 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.600 | 0.400 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.44 | 251 | 324 | 0.774 | 0.0000153 | 3984 |
Missense in Polyphen | 68 | 108.06 | 0.62929 | 1408 | ||
Synonymous | -1.60 | 149 | 126 | 1.18 | 0.00000616 | 1204 |
Loss of Function | 3.35 | 4 | 20.3 | 0.197 | 0.00000118 | 242 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.526
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.914
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Epm2aip1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- response to insulin;positive regulation of glycogen biosynthetic process;positive regulation of glycogen (starch) synthase activity
- Cellular component
- nucleus;endoplasmic reticulum
- Molecular function
- protein binding;identical protein binding